deepc closes Series A extension to accelerate global deployment of healthcare AI, bringing total funding to $30m

• Investment round was co-led by Sofinnova Partners and Bertelsmann Investments, with participation from new investors KHP Ventures and SwissHealth Ventures, and existing investor Winning Mindset Ventures
• The investment will enable deepc to accelerate growth and further develop its industry-leading AI operating system, deepcOS®

Munich, Germany - 25 July 2024 - deepc, the company behind ​​the leading AI operating system for radiologists and enterprise clinical organizations, announced today the closure of its Series A with a $13m extension round, bringing the company’s total funding to date to $30m. The funding was co-led by Sofinnova Partners and Bertelsmann Investments, with participation from new investors KHP Ventures and SwissHealth Ventures, alongside existing investor Winning Mindset Ventures.

The funding will be used to accelerate deepc’s growth and international expansion, as well as further enhance and commercialize its industry-leading operating system. Key priorities for growth include extending deepc’s presence in the United States, further expanding in the United Kingdom and doubling down on key European markets.

Today, deepc’s platform is used by leading organizations including Solothurn Hospital in Switzerland, the Vivantes Hospital Group and LMU University Hospital in Germany, CHU Brugmann (Brugmann University Hospital) in Belgium, as well as the National Health Service (NHS) in England. ‍

Dr. Franz Pfister, CEO and Co-Founder of deepc, said: "At deepc, we believe that the potential for AI in healthcare will only be realized if we can bridge the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to adopt the best AI technologies at pace and at scale, enabling faster, more accurate diagnoses and ultimately improving patient outcomes. We are thrilled to welcome SwissHealth Ventures and KHP Ventures, alongside our existing investors Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures. Together, they bring tremendous strategic value to deepc and will be a major asset as we continue to scale internationally and invest further in our platform."

‍Simon Turner, Partner at Sofinnova Partners, said: "The influx of capital into AI is highlighting the importance of enabling technologies that drive adoption in healthcare. These enabling technologies are the focus of the Sofinnova Digital Medicine strategy, and an area that few have yet to command. From the outset, we recognized deepc's potential to revolutionize AI deployment in healthcare. This conviction is reinforced today by the support of our new investors who bring a wealth of expertise to further accelerate the company's growth.

Founded in 2019, deepc is driven by a vision to help ensure precise and safe diagnostics for all patients and has a strong track record of helping radiology AI providers deploy their technologies in clinical settings through a single integration solution.

Through deepcOS®, clinicians can access regulatory-approved AI solutions for more than 60 clinical indications, allowing healthcare providers to benefit from the rapid developments taking place within radiology AI without any of the technical, operational, or commercial complexity. By giving AI developers low-friction access to deepc’s broad customer base and distribution network spanning over 30 countries, deepc is also helping accelerate the development of new AI solutions.

About deepc
deepc has developed the radiology AI platform deepcOS®, providing clinicians with effortless access to a myriad of regulatory-approved globally leading AI solutions for more than 60 clinical indications, delivering more efficient workflows and assisting radiologists in their daily routine. With its rigorous validation of vendor-neutral AI solutions using large-scale independent data, as well as offering a practical evaluation of AI solutions on local clinical data, deepc ensures that radiologists benefit from the best AI solutions that meet their unique requirements. deepc enables easy and fast installation, end-to-end integration, and unified contracting and billing, service, all under a comprehensive privacy & security framework

Press contact
‍deepc@thisisoutcast.com

About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.8 billion under management. For more information, please visit: www.sofinnovapartners.com.

‍About Bertelsmann Investments
‍Bertelsmann Investments (BI) comprises Bertelsmann’s global venture capital activities as well as the Bertelsmann Next growth unit. The venture capital arm includes the funds Bertelsmann Asia Investments (BAI), Bertelsmann India Investments (BII) and Bertelsmann Digital Media Investments (BDMI), as well as selected fund and direct holdings in markets including Europe, the United States, Brazil, Southeast Asia, and Africa. The Bertelsmann Next unit advances the entrepreneurial development of new growth sectors and business areas, including digital health, HR Tech and mobile ad tech. To date, around €1.9 billion has been invested in about 500 innovative companies and funds through Bertelsmann Investments. Bertelsmann Investments currently holds over 350 active investments worldwide through its network of start-ups and funds.

Press contact
‍jan.hoelkemann@bertelsmann.de

‍About SwissHealth Ventures
‍SwissHealth Ventures is a corporate venture capital firm focused on shaping the future of healthcare. It primarily invests in innovative European start-ups that offer digital health solutions relevant to the Swiss healthcare market. The firm’s investment areas include digital health insurance, telemedicine, mental health, and technologies that enhance patient care and health management efficiency. SwissHealth Ventures is committed to supporting start-ups that not only improve patient outcomes but also aim to reduce healthcare costs through innovative solutions. SwissHealth Ventures AG is part of the CSS Group.

‍About KHP Ventures
‍KHP Ventures is the first NHS-anchored venture fund, investing in clinical innovators and enabling adoption of transformative solutions at scale. KHP Ventures launched in 2021 with the support of Guy’s & St. Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust and King’s College London, one of the largest teaching hospital systems in the UK and Europe. The firm has since expanded to work with other leading health systems across the UK and in the US, alongside a growing portfolio of best-in-class health tech companies.

‍